糖化产生拓上不同的α-Synuclein寡合菌株,并通过NLRP3-Inflammasome路径调节微质反应
Manisha Kumari1, Krishna Singh Bisht1, Kriti Ahuja2
1Functional Proteomics Laboratory, Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, Faridabad 121001, India.
ACS chemical neuroscience
|September 25, 2024
概括
糖化会改变α-synuclein (α-synuclein) 的聚合,从而产生有毒的寡合体. 这些改性寡聚物触发了独特的微质免疫反应,影响神经炎症和神经元存活在synucleinopathies.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 阿尔法-同核素 (α-synuclein) 聚合是帕金森病和相关的同核素病变的核心.
- 微质细胞,大脑的免疫细胞,对不同的α-synuclein菌株表现出不同的反应,影响神经炎症.
- 翻译后的修改,如糖化,增加了α-synuclein在疾病发病过程中的作用的复杂性.
研究的目的:
- 为了研究糖化对α-synuclein聚合的影响.
- 为了描述由此产生的微质对糖化α-同核素寡合体的反应.
- 阐明受改性α-synuclein诱导的神经炎症的特定机制.
主要方法:
- 生物物理分析以表征糖化α-同核素寡合体形态和表面特性.
- 细胞测试测量细胞溶液Ca2+水平,氧化还原应激和线粒体稳定性.
- 对托尔类受体 (TLR) 2和TLR4相互作用以及下游信号通路的研究.
- 评估NLRP3炎症酶激活在对糖化α-synuclein的反应中.
主要成果:
- 糖化α-synuclein寡合体显示出改变的形态,增加的疏水性和受损的膜相互作用.
- 暴露于糖化α-synuclein寡合体诱导了更大的细胞质Ca2+失调,氧化还原应激和线粒体不稳定性.
- 糖化α-synuclein寡合体显示与TLR2的结合减少,但促进了TLR4的内细胞分裂和降解.
- 这些改性寡合物优先激活NLRP3炎症酶介导的神经炎症.
结论:
- 糖化显著改变α-synuclein寡合体的结构和特性,影响细胞反应.
- 微质表现出明显的炎症特征,以响应糖化与未修改的α-synuclein oligomers.
- 这项研究揭示了与同核蛋白病变相关的构造特异性微质激活机制.
关键词:
含有NOD-LRR和pyrin域的蛋白3 (NLRP3) 的蛋白质.帕金森病是帕金森氏症的一种疾病.糖化α-同核素是一种糖性α-同核素.微质细胞中的微质细胞收费类感应器 2 类似收费类感应器α-synuclein 是一种同核蛋白.更多相关视频
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
7.5K
08:24A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
2.2K
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
